Rockefeller Capital Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
BFG
Rockefeller Capital Management's FBT Position: Q2 2026 in Review
Rockefeller Capital Management reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 0.19% in Q2 2026, selling an estimated $5.82K and leaving 14,107 shares worth $3.5M. The position accounts for 0.01% of the portfolio, ranked #1129.
Rockefeller Capital Management first reported a position in FBT in Q1 2019 and has held it in 22 quarters since. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.
- Rockefeller Capital Management held 14,107 shares of First Trust NYSE Arca Biotechnology Index Fund worth $3.5M as of Q2 2026.
- Rockefeller Capital Management sold 27 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $5.82K.
- First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #1129 holding.
- Rockefeller Capital Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2019 and has held it in 22 quarters since.
- 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.
Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.